A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma.
Veronica SwystunFrancis H Y GreenJohn H DennisEmmanouil RampakakisGurkeet LalliMorenike FadayomiAndrea ChiuGrishma ShresthaSharif Galal El ShahatDavid Evan NelsonTamer Y El MaysCora A PieronRichard LeighPublished in: Trials (2018)
ClinicalTrials.gov, NCT02334553 . Registered on 12 November 2014.
Keyphrases
- double blind
- placebo controlled
- clinical trial
- phase ii
- phase iii
- liver failure
- chronic obstructive pulmonary disease
- study protocol
- respiratory failure
- lung function
- phase ii study
- drug induced
- aortic dissection
- allergic rhinitis
- open label
- randomized controlled trial
- hepatitis b virus
- air pollution
- extracorporeal membrane oxygenation